Glaxo CEO Witty: More Transparency Needed in Drug Pricing

Andrew Witty, GlaxoSmithKline's chief executive officer, discusses the company's growth prospects, the Pfizer-Allergan talks and drug pricing. He speaks with Bloomberg's Erik Schatzker and Cynthia Koons on "What'd You Miss?" (Source: Bloomberg)

American Health Care Act: Industry Winners and Losers
34:19 - As the House vote on the American Health Care Act looms later today in Washington, D.C., Bloomberg's Zach Tracer examines the health care industry's potential winners and losers if the bill gets approved. He speaks on "Bloomberg Markets." (Source: Bloomberg)
  • NMC Health CEO Sees Global Asset Buying Opportunities
  • Full Show: Bloomberg Daybreak: Americas (03/01)
  • Full Show: Bloomberg Daybreak: Americas (02/09)